LIPOCINE INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value
LIPOCINE INC. (LPCN) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value of $18.29 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate · last filed 2026-08-04
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $18.29M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $19.71M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $9.72M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value $11.23M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value |
|---|---|
| 2026-06-30 | $18.29M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $19.71M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $9.72M 10-K · filed 2026-03-10 |
| 2025-09-30 | $11.23M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $11.89M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $16.36M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $15.43M 10-K · filed 2025-03-13 |
| 2024-06-30 | $17.00M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $21.55M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $17.26M 10-K · filed 2024-03-07 |
| 2023-09-30 | $19.78M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $20.78M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $24.10M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $29.38M 10-K · filed 2023-03-10 |
| 2022-09-30 | $31.86M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $32.41M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $36.27M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $43.69M 10-K · filed 2022-03-09 |
| 2021-09-30 | $34.15M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $35.67M 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |